Global Gastrointestinal Stromal Tumor (GIST) Drug market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. Get access now!

Global Gastrointestinal Stromal Tumor (GIST) Drug Market Trends and Opportunities 2025-31

The global Gastrointestinal Stromal Tumor (GIST) Drug market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. Infinity Market Research newest research report, the Gastrointestinal Stromal Tumor (GIST) Drug Industry Forecast looks at past sales and reviews total world Gastrointestinal Stromal Tumor (GIST) Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Gastrointestinal Stromal Tumor (GIST) Drug sales for 2025 through 2031. With Gastrointestinal Stromal Tumor (GIST) Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gastrointestinal Stromal Tumor (GIST) Drug industry. This Insight Report provides a comprehensive analysis of the global Gastrointestinal Stromal Tumor (GIST) Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gastrointestinal Stromal Tumor (GIST) Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Gastrointestinal Stromal Tumor (GIST) Drug market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gastrointestinal Stromal Tumor (GIST) Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gastrointestinal Stromal Tumor (GIST) Drug. This report presents a comprehensive overview, market shares, and growth opportunities of Gastrointestinal Stromal Tumor (GIST) Drug market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Amcasertib &nbsp;&nbsp;&nbsp; Anagrelide hydrochloride CR &nbsp;&nbsp;&nbsp; APG-1351 &nbsp;&nbsp;&nbsp; Binimetinib &nbsp;&nbsp;&nbsp; Others Segmentation by Application: &nbsp;&nbsp;&nbsp; Clinic &nbsp;&nbsp;&nbsp; Hospital &nbsp;&nbsp;&nbsp; Others This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Ariad Pharmaceuticals, Inc. &nbsp;&nbsp;&nbsp; Arog Pharmaceuticals, Inc. &nbsp;&nbsp;&nbsp; Array BioPharma Inc. &nbsp;&nbsp;&nbsp; Astex Pharmaceuticals, Inc. &nbsp;&nbsp;&nbsp; Blueprint Medicines Corporation &nbsp;&nbsp;&nbsp; Boston Biomedical, Inc. &nbsp;&nbsp;&nbsp; Calithera Biosciences, Inc. &nbsp;&nbsp;&nbsp; Chipscreen Biosciences Ltd &nbsp;&nbsp;&nbsp; Deciphera Pharmaceuticals, LLC &nbsp;&nbsp;&nbsp; F. Hoffmann-La Roche Ltd. &nbsp;&nbsp;&nbsp; Horizon Pharma Plc &nbsp;&nbsp;&nbsp; Immunicum AB &nbsp;&nbsp;&nbsp; Jiangsu Hengrui Medicine Co., Ltd. &nbsp;&nbsp;&nbsp; Kolltan Pharmaceuticals, Inc. &nbsp;&nbsp;&nbsp; Natco Pharma Limited &nbsp;&nbsp;&nbsp; Nerviano Medical Sciences S.r.l. &nbsp;&nbsp;&nbsp; Novartis AG &nbsp;&nbsp;&nbsp; Omeros Corporation Key Questions Addressed in this Report What is the 10-year outlook for the global Gastrointestinal Stromal Tumor (GIST) Drug market? What factors are driving Gastrointestinal Stromal Tumor (GIST) Drug market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Gastrointestinal Stromal Tumor (GIST) Drug market opportunities vary by end market size? How does Gastrointestinal Stromal Tumor (GIST) Drug break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Gastrointestinal Stromal Tumor (GIST) Drug by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Gastrointestinal Stromal Tumor (GIST) Drug by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Gastrointestinal Stromal Tumor (GIST) Drug Segment by Type &nbsp;2.2.1 Amcasertib &nbsp;2.2.2 Anagrelide hydrochloride CR &nbsp;2.2.3 APG-1351 &nbsp;2.2.4 Binimetinib &nbsp;2.2.5 Others &nbsp;2.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type &nbsp;2.3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Sale Price by Type (2020-2025) &nbsp;2.4 Gastrointestinal Stromal Tumor (GIST) Drug Segment by Application &nbsp;2.4.1 Clinic &nbsp;2.4.2 Hospital &nbsp;2.4.3 Others &nbsp;2.5 Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application &nbsp;2.5.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Breakdown Data by Company &nbsp;3.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Company (2020-2025) &nbsp;3.2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Sale Price by Company &nbsp;3.4 Key Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Product Location Distribution &nbsp;3.4.2 Players Gastrointestinal Stromal Tumor (GIST) Drug Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Gastrointestinal Stromal Tumor (GIST) Drug by Geographic Region &nbsp;4.1 World Historic Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth &nbsp;4.4 APAC Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth &nbsp;4.5 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth &nbsp;4.6 Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth 5 Americas &nbsp;5.1 Americas Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country &nbsp;5.1.1 Americas Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2020-2025) &nbsp;5.1.2 Americas Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2020-2025) &nbsp;5.2 Americas Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2020-2025) &nbsp;5.3 Americas Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region &nbsp;6.1.1 APAC Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region (2020-2025) &nbsp;6.1.2 APAC Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Region (2020-2025) &nbsp;6.2 APAC Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2020-2025) &nbsp;6.3 APAC Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug by Country &nbsp;7.1.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2020-2025) &nbsp;7.1.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2020-2025) &nbsp;7.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2020-2025) &nbsp;7.3 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug by Country &nbsp;8.1.1 Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Gastrointestinal Stromal Tumor (GIST) Drug &nbsp;10.3 Manufacturing Process Analysis of Gastrointestinal Stromal Tumor (GIST) Drug &nbsp;10.4 Industry Chain Structure of Gastrointestinal Stromal Tumor (GIST) Drug 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Gastrointestinal Stromal Tumor (GIST) Drug Distributors &nbsp;11.3 Gastrointestinal Stromal Tumor (GIST) Drug Customer 12 World Forecast Review for Gastrointestinal Stromal Tumor (GIST) Drug by Geographic Region &nbsp;12.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Forecast by Region &nbsp;12.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Forecast by Region (2026-2031) &nbsp;12.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Gastrointestinal Stromal Tumor (GIST) Drug Forecast by Type (2026-2031) &nbsp;12.7 Global Gastrointestinal Stromal Tumor (GIST) Drug Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 Ariad Pharmaceuticals, Inc. &nbsp;13.1.1 Ariad Pharmaceuticals, Inc. Company Information &nbsp;13.1.2 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolios and Specifications &nbsp;13.1.3 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 Ariad Pharmaceuticals, Inc. Main Business Overview &nbsp;13.1.5 Ariad Pharmaceuticals, Inc. Latest Developments &nbsp;13.2 Arog Pharmaceuticals, Inc. &nbsp;13.2.1 Arog Pharmaceuticals, Inc. Company Information &nbsp;13.2.2 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolios and Specifications &nbsp;13.2.3 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 Arog Pharmaceuticals, Inc. Main Business Overview &nbsp;13.2.5 Arog Pharmaceuticals, Inc. Latest Developments &nbsp;13.3 Array BioPharma Inc. &nbsp;13.3.1 Array BioPharma Inc. Company Information &nbsp;13.3.2 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolios and Specifications &nbsp;13.3.3 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 Array BioPharma Inc. Main Business Overview &nbsp;13.3.5 Array BioPharma Inc. Latest Developments &nbsp;13.4 Astex Pharmaceuticals, Inc. &nbsp;13.4.1 Astex Pharmaceuticals, Inc. Company Information &nbsp;13.4.2 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolios and Specifications &nbsp;13.4.3 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 Astex Pharmaceuticals, Inc. Main Business Overview &nbsp;13.4.5 Astex Pharmaceuticals, Inc. Latest Developments &nbsp;13.5 Blueprint Medicines Corporation &nbsp;13.5.1 Blueprint Medicines Corporation Company Information &nbsp;13.5.2 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolios and Specifications &nbsp;13.5.3 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.5.4 Blueprint Medicines Corporation Main Business Overview &nbsp;13.5.5 Blueprint Medicines Corporation Latest Developments &nbsp;13.6 Boston Biomedical, Inc. &nbsp;13.6.1 Boston Biomedical, Inc. Company Information &nbsp;13.6.2 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolios and Specifications &nbsp;13.6.3 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.6.4 Boston Biomedical, Inc. Main Business Overview &nbsp;13.6.5 Boston Biomedical, Inc. Latest Developments &nbsp;13.7 Calithera Biosciences, Inc. &nbsp;13.7.1 Calithera Biosciences, Inc. Company Information &nbsp;13.7.2 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolios and Specifications &nbsp;13.7.3 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.7.4 Calithera Biosciences, Inc. Main Business Overview &nbsp;13.7.5 Calithera Biosciences, Inc. Latest Developments &nbsp;13.8 Chipscreen Biosciences Ltd &nbsp;13.8.1 Chipscreen Biosciences Ltd Company Information &nbsp;13.8.2 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolios and Specifications &nbsp;13.8.3 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.8.4 Chipscreen Biosciences Ltd Main Business Overview &nbsp;13.8.5 Chipscreen Biosciences Ltd Latest Developments &nbsp;13.9 Deciphera Pharmaceuticals, LLC &nbsp;13.9.1 Deciphera Pharmaceuticals, LLC Company Information &nbsp;13.9.2 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolios and Specifications &nbsp;13.9.3 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.9.4 Deciphera Pharmaceuticals, LLC Main Business Overview &nbsp;13.9.5 Deciphera Pharmaceuticals, LLC Latest Developments &nbsp;13.10 F. Hoffmann-La Roche Ltd. &nbsp;13.10.1 F. Hoffmann-La Roche Ltd. Company Information &nbsp;13.10.2 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolios and Specifications &nbsp;13.10.3 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.10.4 F. Hoffmann-La Roche Ltd. Main Business Overview &nbsp;13.10.5 F. Hoffmann-La Roche Ltd. Latest Developments &nbsp;13.11 Horizon Pharma Plc &nbsp;13.11.1 Horizon Pharma Plc Company Information &nbsp;13.11.2 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolios and Specifications &nbsp;13.11.3 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.11.4 Horizon Pharma Plc Main Business Overview &nbsp;13.11.5 Horizon Pharma Plc Latest Developments &nbsp;13.12 Immunicum AB &nbsp;13.12.1 Immunicum AB Company Information &nbsp;13.12.2 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolios and Specifications &nbsp;13.12.3 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.12.4 Immunicum AB Main Business Overview &nbsp;13.12.5 Immunicum AB Latest Developments &nbsp;13.13 Jiangsu Hengrui Medicine Co., Ltd. &nbsp;13.13.1 Jiangsu Hengrui Medicine Co., Ltd. Company Information &nbsp;13.13.2 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolios and Specifications &nbsp;13.13.3 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.13.4 Jiangsu Hengrui Medicine Co., Ltd. Main Business Overview &nbsp;13.13.5 Jiangsu Hengrui Medicine Co., Ltd. Latest Developments &nbsp;13.14 Kolltan Pharmaceuticals, Inc. &nbsp;13.14.1 Kolltan Pharmaceuticals, Inc. Company Information &nbsp;13.14.2 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolios and Specifications &nbsp;13.14.3 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.14.4 Kolltan Pharmaceuticals, Inc. Main Business Overview &nbsp;13.14.5 Kolltan Pharmaceuticals, Inc. Latest Developments &nbsp;13.15 Natco Pharma Limited &nbsp;13.15.1 Natco Pharma Limited Company Information &nbsp;13.15.2 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolios and Specifications &nbsp;13.15.3 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.15.4 Natco Pharma Limited Main Business Overview &nbsp;13.15.5 Natco Pharma Limited Latest Developments &nbsp;13.16 Nerviano Medical Sciences S.r.l. &nbsp;13.16.1 Nerviano Medical Sciences S.r.l. Company Information &nbsp;13.16.2 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolios and Specifications &nbsp;13.16.3 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.16.4 Nerviano Medical Sciences S.r.l. Main Business Overview &nbsp;13.16.5 Nerviano Medical Sciences S.r.l. Latest Developments &nbsp;13.17 Novartis AG &nbsp;13.17.1 Novartis AG Company Information &nbsp;13.17.2 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolios and Specifications &nbsp;13.17.3 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.17.4 Novartis AG Main Business Overview &nbsp;13.17.5 Novartis AG Latest Developments &nbsp;13.18 Omeros Corporation &nbsp;13.18.1 Omeros Corporation Company Information &nbsp;13.18.2 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolios and Specifications &nbsp;13.18.3 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.18.4 Omeros Corporation Main Business Overview &nbsp;13.18.5 Omeros Corporation Latest Developments 14 Research Findings and Conclusion

Report	Global Gastrointestinal Stromal Tumor (GIST) Drug Market Growth 2025-2031
Selected License	Multi ID: LPI21089

Buyer Information

Order Summary